A Study With CIT-013 in HS Patients — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study With CIT-013 in HS Patients — Stella

Recruiting

Back to Hidradenitis Suppurativa (HS) trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(24 sites)

Canada

CA-01, Barrie

CA-05, Calgary

CA-02, London

CA-04, Newmarket

CA-03, Winnipeg

Key details

Phase

Safety & dosing

Sponsor

Citryll BV

Enrollment target

~96 participants

Started

October 2025

Primary completion

April 2027

Age range

18 Years and older

Last updated March 2026

Interested in joining?

View full record on ClinicalTrials.gov

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.